Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Bandmann

Showing results (21-30 of 88) with videos related to

Pageof 9
Sort By:
Plos Currents|September 7, 2012
The Prevalence of Juvenile Huntington's Disease: A Review of the Literature and Meta-AnalysisOliver Quarrell, Kirsty L O'Donovan, Oliver Bandmann, et al.
Journal of Neurochemistry|December 15, 2006
p53-dependent neuronal cell death in a DJ-1-deficient zebrafish model of Parkinson's diseaseSandrine Bretaud, Claire Allen, Phillip W Ingham, et al.
Neurology and Therapy|July 18, 2025
Neuroprotection in Parkinson DiseaseCristina Gonzalez-Robles, Oliver Bandmann, Anthony H V Schapira
Practical Neurology|August 30, 2020
Neurological letter from BangladeshMohammad Selim Shahi, Tauhidul Islam Chowdhury, Oliver Bandmann, et al.
Neurology|December 1, 2010
Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2Heather Mortiboys, Krisztina K Johansen, Jan O Aasly, et al.
Neural Regeneration Research|September 28, 2020
Targeting mechanisms in cognitive training for neurodegenerative diseasesAnnalena Venneri, Riccardo Manca, Linford Fernandes, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 3, 2021
Wilson's disease: update on pathogenesis, biomarkers and treatmentsSamuel Shribman, Aurelia Poujois, Oliver Bandmann, et al.
Journal of Neurochemistry|May 10, 2008
Zebrafish as a new animal model for movement disordersLaura Flinn, Sandrine Bretaud, Christine Lo, et al.
Biology Open|September 25, 2019
Restriction of mitochondrial calcium overload by <i>mcu</i> inactivation renders a neuroprotective effect in zebrafish models of Parkinson's diseaseSmijin K Soman, Michal Bazała, Marcus Keatinge, et al.
The Lancet. Neurology|June 19, 2021
Progress towards therapies for disease modification in Parkinson's diseaseNirosen Vijiaratnam, Tanya Simuni, Oliver Bandmann, et al.
Pageof 9

Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
Plos Currents|September 7, 2012
The Prevalence of Juvenile Huntington's Disease: A Review of the Literature and Meta-AnalysisOliver Quarrell, Kirsty L O'Donovan, Oliver Bandmann, et al.
Journal of Neurochemistry|December 15, 2006
p53-dependent neuronal cell death in a DJ-1-deficient zebrafish model of Parkinson's diseaseSandrine Bretaud, Claire Allen, Phillip W Ingham, et al.
Neurology and Therapy|July 18, 2025
Neuroprotection in Parkinson DiseaseCristina Gonzalez-Robles, Oliver Bandmann, Anthony H V Schapira
Practical Neurology|August 30, 2020
Neurological letter from BangladeshMohammad Selim Shahi, Tauhidul Islam Chowdhury, Oliver Bandmann, et al.
Neurology|December 1, 2010
Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2Heather Mortiboys, Krisztina K Johansen, Jan O Aasly, et al.
Neural Regeneration Research|September 28, 2020
Targeting mechanisms in cognitive training for neurodegenerative diseasesAnnalena Venneri, Riccardo Manca, Linford Fernandes, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 3, 2021
Wilson's disease: update on pathogenesis, biomarkers and treatmentsSamuel Shribman, Aurelia Poujois, Oliver Bandmann, et al.
Journal of Neurochemistry|May 10, 2008
Zebrafish as a new animal model for movement disordersLaura Flinn, Sandrine Bretaud, Christine Lo, et al.
Biology Open|September 25, 2019
Restriction of mitochondrial calcium overload by <i>mcu</i> inactivation renders a neuroprotective effect in zebrafish models of Parkinson's diseaseSmijin K Soman, Michal Bazała, Marcus Keatinge, et al.
The Lancet. Neurology|June 19, 2021
Progress towards therapies for disease modification in Parkinson's diseaseNirosen Vijiaratnam, Tanya Simuni, Oliver Bandmann, et al.
Pageof 9